Related Experiment Videos
Phosphate isosteres in medicinal chemistry
1The Walter and Eliza Hall Institute of Medical Research Biotechnology Centre, Division of Structural Biology, Bundoora, VIC 3086, Australia. rye@wehi.edu.au
Current Medicinal Chemistry
|December 27, 2005
Summary
Phosphate groups are crucial in biology and disease. Phosphate isosteres offer stable, less charged alternatives for drug development, improving therapeutic potential.
Area of Science:
- Medicinal Chemistry
- Biochemistry
- Drug Discovery
Background:
- Phosphate groups are central to numerous biological processes, including protein activity and cellular localization.
- Abnormal protein phosphorylation is implicated in diseases like cancer and diabetes.
- Proteins recognizing phosphate groups are key therapeutic targets.
Purpose of the Study:
- To review recent advancements in phosphate isosteres for medicinal chemistry.
- To highlight the development of phosphate mimics as therapeutic agents.
- To discuss the challenges and strategies in targeting phosphate-binding proteins.
Main Methods:
- Focus on non-catalytic phosphotyrosine-recognizing domains (e.g., SH2, PTB) and catalytic proteins (e.g., PTP1B).
- Exploration of phosphate isosteres to overcome limitations of native phosphate groups (lability, charge).
- Analysis of recent literature (past four years) on phosphate mimic development.
Main Results:
- Phosphate isosteres offer improved stability and cellular bioavailability compared to native phosphates.
- Isosteres utilize non-scissile bonds and reduced charge for favorable protein interactions.
- Examples include fluoromethylenephosphonates and carboxylate-based mimics.
Conclusions:
- Phosphate isosteres represent a promising strategy in medicinal chemistry for drug development.
- Mimicking phosphate interactions can lead to novel therapeutics for diseases linked to phosphorylation.
- Continued research into diverse phosphate mimics is essential for expanding therapeutic options.